Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline-Propranolol vs Pizotifen for Migraine Prophylaxis
NCT06158230Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of pizotifen in migraine (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Frequency of headache per month at 12 weeks, Duration of headache per month at 12 weeks and 1 more. Status: unknown.
02
Drugs
pizotifen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06158230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158230.